Suppr超能文献

总蛋白、白蛋白、球蛋白、血清-胸水白蛋白梯度及乳酸脱氢酶在结核与癌所致胸腔积液鉴别诊断中的意义

Significance of Total Protein, Albumin, Globulin, Serum Effusion Albumin Gradient and LDH in the Differential Diagnosis of Pleural Effusion Secondary to Tuberculosis and Cancer.

作者信息

Samanta Sumeru, Sharma Ashish, Das Biswajit, Mallick Ayaz K, Kumar Amit

机构信息

Assistant Professor and Research Fellow, Department of Biochemistry, Rohilkhand Medical College and Hospital , Bareilly, Uttar Pradesh, India .

Associate Professor and Guide, Department of Biochemistry, Geetanjali Medical College and Hospital, Geetanjali University , Udaipur, Uttar Pradesh, India .

出版信息

J Clin Diagn Res. 2016 Aug;10(8):BC14-8. doi: 10.7860/JCDR/2016/20652.8379. Epub 2016 Aug 1.

Abstract

INTRODUCTION

Lung cancer and Pulmonary tuberculosis are two major public health problems associated with significant morbidity and mortality worldwide particularly in low and middle income countries like India. Wrong diagnosis of lung cancer cases as pulmonary tuberculosis in primary health care system delays the onset of anti-cancer chemotherapy as well as initiation of DOTS thus increasing complication and mortality rate in malignancy patients. In this context easy, cost effective diagnostic tool at primary level must be the priority and need of hour.

AIM

To study and evaluate any significance of biochemical parameters (total protein, albumin, globulin, serum effusion albumin gradient, LDH) in serum and pleural effusion secondary to tuberculosis and lung cancer.

MATERIALS AND METHODS

A case control study was carried out on patients attending OPD and IPD, Department of Pulmonary Medicine, RMCH. Hundred cases of Tuberculosis effusion, 50 cases of Malignant effusion and 100 age and sex matched apparently healthy controls were taken for correlation of biochemical parameters (total protein, albumin, globulin, serum effusion albumin gradient, LDH) and statistically evaluated to find any significance between tuberculosis, lung cancer and control group. Blood and pleural fluid samples were collected and then subjected to assessment of parameters (total protein, albumin, LDH) by using EM360 Autoanalyser and kits were supplied by Transasia diagnostics. Globulin and Serum Effusion Albumin Gradient (SEAG) was calculated mathematically.

STATISTICAL ANALYSIS

Data is presented as mean ± SD. Comparison of serum and pleural fluid levels (of taken parameters) were done in TB, Lung Cancer and Control groups by ANOVA and students t-test. The p-value <0.05 were considered as statistically significant.

RESULTS

We found serum-total protein, albumin, globulin to be significantly higher in TB group than lung cancer group but serum LDH was higher in lung cancer group (in all parameters p=<0.0001). Pleural Fluid-total protein, albumin, globulin was again significantly higher in TB group than lung cancer group and LDH was higher in lung cancer group (p=<0.0001). SEAG is also significantly higher in TB group than lung cancer group (p=<0.002).

CONCLUSION

The results suggests early quantization of these parameters can differentiate pulmonary tuberculosis from lung cancer and thus can decrease the mortality rate of lung cancer cases though more extensive study with increased sample size may provide more insights.

摘要

引言

肺癌和肺结核是两个主要的公共卫生问题,在全球范围内,尤其是在印度等低收入和中等收入国家,它们会导致很高的发病率和死亡率。在初级卫生保健系统中,将肺癌病例误诊为肺结核会延迟抗癌化疗的开始以及直接观察短程疗法(DOTS)的启动,从而增加恶性肿瘤患者的并发症和死亡率。在这种情况下,初级层面简单且经济高效的诊断工具必须成为当务之急和迫切需求。

目的

研究和评估生化参数(总蛋白、白蛋白、球蛋白、血清-胸水白蛋白梯度、乳酸脱氢酶)在继发于肺结核和肺癌的血清及胸水中的任何意义。

材料与方法

对在RMCH肺科门诊和住院部就诊的患者进行了一项病例对照研究。选取了100例结核性胸水病例、50例恶性胸水病例以及100例年龄和性别匹配的明显健康对照,以关联生化参数(总蛋白、白蛋白、球蛋白、血清-胸水白蛋白梯度、乳酸脱氢酶),并进行统计学评估,以找出肺结核、肺癌和对照组之间的任何差异。采集血液和胸水样本,然后使用EM3X自动分析仪对参数(总蛋白、白蛋白、乳酸脱氢酶)进行评估,试剂盒由Transasia诊断公司提供。球蛋白和血清-胸水白蛋白梯度(SEAG)通过数学计算得出。

统计分析

数据以平均值±标准差表示。通过方差分析和学生t检验对结核组、肺癌组和对照组的血清和胸水水平(所取参数)进行比较。p值<0.05被认为具有统计学意义。

结果

我们发现结核组的血清总蛋白、白蛋白、球蛋白显著高于肺癌组,但肺癌组的血清乳酸脱氢酶更高(所有参数p<0.0001)。结核组的胸水总蛋白、白蛋白、球蛋白再次显著高于肺癌组,肺癌组的乳酸脱氢酶更高(p<0.0001)。结核组的SEAG也显著高于肺癌组(p<0.002)。

结论

结果表明,这些参数的早期量化可以区分肺结核和肺癌,从而可以降低肺癌病例的死亡率,不过样本量增加的更广泛研究可能会提供更多见解。

相似文献

3
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).
Lung. 2016 Feb;194(1):147-53. doi: 10.1007/s00408-015-9831-6. Epub 2015 Dec 17.
4
Pleural fluid MDA and serum-effusion albumin gradient in pleural effusion.
Indian J Clin Biochem. 2008 Jan;23(1):81-4. doi: 10.1007/s12291-008-0019-1. Epub 2008 Mar 6.
5
Lactic dehydrogenase isoenzyme electrophoretic patterns in the diagnosis of pleural effusion.
Cancer. 1984 Aug 1;54(3):507-11. doi: 10.1002/1097-0142(19840801)54:3<507::aid-cncr2820540320>3.0.co;2-4.
8
The serum-effusion albumin gradient in the evaluation of pleural effusions.
Chest. 1990 Sep;98(3):546-9. doi: 10.1378/chest.98.3.546.
9
Clinical characteristics and potential indicators for definite diagnosis of tuberculous pleural effusion.
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1924-1931. doi: 10.1080/21691401.2019.1613417.

引用本文的文献

1
2
Changes in nonfunctional adrenal incidentaloma after COVID-19 infection and a model for predicting benign and malignant adrenal incidentaloma.
Front Endocrinol (Lausanne). 2024 Sep 2;15:1374282. doi: 10.3389/fendo.2024.1374282. eCollection 2024.
7
Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.
Pleura Peritoneum. 2021 Apr 19;6(2):83-90. doi: 10.1515/pp-2021-0111. eCollection 2021 Jun.
10
Malignant Pleural Effusion and Its Current Management: A Review.
Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490.

本文引用的文献

3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
Clinical and laboratory parameters in the differential diagnosis of pleural effusion secondary to tuberculosis or cancer.
Clinics (Sao Paulo). 2007 Oct;62(5):585-90. doi: 10.1590/s1807-59322007000500009.
6
Diagnosis and treatment of tuberculous pleural effusion in 2006.
Chest. 2007 Mar;131(3):880-889. doi: 10.1378/chest.06-2063.
7
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.
J Clin Oncol. 2006 May 20;24(15):2245-51. doi: 10.1200/JCO.2005.04.8033.
8
Global cancer statistics, 2002.
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
9
BTS guidelines for the management of malignant pleural effusions.
Thorax. 2003 May;58 Suppl 2(Suppl 2):ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验